This inventor holds 8 USPTO granted patents and 8 published patent applications and 1 EPO patent. Top assignee: Incyte Corporation. Active years: 2021-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021-2026
Title: Minh Nguyen: Innovator in Pharmaceutical Compounds
Introduction
Minh Nguyen is a notable inventor based in Claymont, DE (US), recognized for his contributions to the field of pharmaceutical compounds. With a total of 8 patents, he has made significant strides in developing innovative solutions for treating diseases associated with ALK2 and FGFR activities.
Latest Patents
Nguyen's latest patents include groundbreaking work on Pyrazolopyrimidine compounds. These compounds are designed to inhibit ALK2 and FGFR activity, offering potential treatments for various cancers. Another significant invention is related to bicyclic heterocycles, which serve as inhibitors of the FGFR enzyme, further contributing to the fight against FGFR-associated diseases.
Career Highlights
Minh Nguyen is currently employed at Incyte Corporation, where he continues to advance his research and development efforts. His work is pivotal in the pharmaceutical industry, particularly in creating effective treatments for serious health conditions.
Collaborations
Nguyen collaborates with talented professionals in his field, including Oleg Vechorkin and Wenqing Yao, who contribute to his innovative projects and research initiatives.
Conclusion
Minh Nguyen's work exemplifies the impact of innovation in the pharmaceutical industry, showcasing his dedication to improving health outcomes through his patented inventions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile